Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Onyvax Limited

Onyvax early stage biotech pharmaceuticals immnotherapies for oncology (Cancer).


Contact Details:
PO Box 17717 St George’s Hospital Medical School
London
Greater London
SW17 0WG
United Kingdom
Tel:020 8682 9494
Fax:020 8682 9495
Email:
WWW:

www.onyvax.com/




Loading...

Recent Publications by Onyvax Limited:

Cancer vaccines: will we ever learn?
Scientists and clinicians engaged in developing therapeutic cancer...
3rd March, 2009
Onyvax Ltd, St George's University of London, London, UK. Expert Rev Anticancer Ther. 2009 Jan;9(1):67-74.
DOI Direct Link
Technical challenges facing therapeutic cancer vaccines.
Significant advances have been made in the development of therapeutic...
15th April, 2008
Onyvax Ltd, St George's University of London, Cranmer Terrace, London, Curr Opin Drug Discov Devel. 2008 Mar;11(2):168-77.
The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model.
Allogeneic whole tumour cell vaccines are inherently practical compared...
24th June, 2006
Onyvax Ltd, St George's Hospital Medical School, Cranmer Terrace, Tooting, Cancer Immunol Immunother. 2006 Mar;55(3):277-88. Epub 2005 Sep 13.
DOI Direct Link
A method for the absolute quantification of cDNA using real-time PCR.
Real-time PCR is an extremely powerful technique, however, often its...
31st October, 2003
Onyvax Ltd., St. George's Hospital Medical School, Cranmer Terrace, London J Immunol Methods. 2003 Jul;278(1-2):261-9.
Cancer immunotherapy: an embarrassment of riches?
There is clear evidence that certain forms of immunotherapy can be...
16th May, 2003
Onyvax, St George's Hospital Medical School, Cranmer Terrace, London, UK Drug Discov Today. 2003 Mar 15;8(6):253-8.

View more Onyvax Limited research publications.

Onyvax Limited Clinical Trials:

Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Onyvax Limited Patents:

US Patent No.Title
7438922 Human prostate cell lines in cancer treatment
7303911 Prostate cell lines
6972128 Use of human prostrate cell lines in prostate cancer treatment
6699483 Cancer treatments

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 545 times since April 2007, the link to the organisation's website has been followed 85 times

Recent Search Terms used to find this page: Onyvax Limited St. George s Hospital medical school | onyvax 2009 | onyvax pharmaceuticals news 2009 | Onyvax L T D london | onyvax | onyva | onyvax | onyvax 2009 | Onyvax 2009 news | Technical challenges facing therapeutic cancer vaccines | .

Search for more companies in London

Search for more companies in Greater London



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Onyvax Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.